Chemical Structure : MRTX849
CAS No.: 2326521-71-3
货号: PC-72227Not For Human Use, Lab Use Only.
MRTX849 (Adagrasib, MRTX-849) is a potent, selective, and covalent KRAS G12C inhibitor, inhibits KRAS-dependent signaling.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥580 | In stock | |
10 mg | ¥880 | In stock | |
25 mg | ¥1380 | In stock | |
50 mg | ¥2280 | In stock | |
100 mg | ¥3780 | In stock | |
250 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
MRTX849 (Adagrasib, MRTX-849) is a potent, selective, and covalent KRAS G12C inhibitor, inhibits KRAS-dependent signaling.
MRTX849 (Adagrasib) binds to, stabilizes and selectively modifies mutant cysteine 12 in GDP-bound KRAS G12C, and inhibits KRAS-dependent signaling.
MRTX849 (Adagrasib) inhibited KRAS-dependent signaling targets including ERK1/2 phosphorylation (Thr202/Tyr204 ERK1; pERK), S6 phosphorylation (RSK-dependent Ser235/236; pS6) and expression of the ERK-regulated DUSP6, each with IC50 values in the single-digit nanomolar range in KRASG12C-mutant H358 lung and MIA PaCa-2 pancreatic cancer cell lines.
MRTX849 (Adagrasib) potently inhibited cell growth in the vast majority of KRASG12C-mutant cell lines with IC50 of 10-973 nM.
MRTX849 (Adagrasib) inhibited KRAS signaling and tumor growth in vivo, demonstrated potent anti-tumor activity in KRASG12C-mutant and non KRASG12C-mutant human tumor xenografts models.
分子量 | 604.13 | |
分子式 | C32H35ClFN7O2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
20 mM in DMSO (12.1 mg/mL) |
|
Chemical Name/SMILES |
2-((S)-4-(7-(8-Chloronaphthalen-1-yl)-2-(((S)-1-methylpyrrolidin-2-yl)methoxy)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)-1-(2-fluoroacryloyl)piperazin-2-yl)acetonitrile |
1. Hallin J, et al. Cancer Discov. 2020 Jan;10(1):54-71.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright